Abraxane and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abraxane (paclitaxel) and Gliclazide (gliclazide). Common drug interactions include fatigue among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Abraxane and Gliclazide. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

On Jul, 18, 2026

68 people who take Abraxane and Gliclazide together, and have interactions are studied.

Abraxane and Gliclazide drug interactions.

What are the common drug interactions of Abraxane and Gliclazide, by gender? *:

female:

Fatigue (feeling of tiredness)
Muscular weakness (muscle weakness)
Sepsis (a severe blood infection that can lead to organ failure and death)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Abdominal pain upper
Dry gangrene (diminished blood supply due to vascular problems)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Infection
Pyrexia (fever)
Thrombosis (formation of a blood clot inside a blood vessel)

male:

Pneumonia
Lung infection
Septic shock (shock due to blood infection)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Bladder transitional cell carcinoma (types of bladder cancer)
Neuropathy peripheral (surface nerve damage)
Peroneal nerve palsy
Angina pectoris (chest pain due to ischemia of the heart muscle)
Biliary tract infection
Death

What are the common drug interactions of Abraxane and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal pain upper
Infection
Pyrexia (fever)
Thrombosis (formation of a blood clot inside a blood vessel)
Vomiting

60+:

Pneumonia
Lung infection
Febrile neutropenia (fever with reduced white blood cells)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Bone marrow failure
Catheter site cellulitis (infection of cells near catheter)
Septic shock (shock due to blood infection)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Bladder transitional cell carcinoma (types of bladder cancer)
Dry gangrene (diminished blood supply due to vascular problems)

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 39 people, 57.35%
Constipation: 38 people, 55.88%
Nausea (feeling of having an urge to vomit): 36 people, 52.94%
High Blood Pressure: 30 people, 44.12%
Abdominal Pain: 29 people, 42.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 27 people, 39.71%
Diarrhea: 26 people, 38.24%
High Blood Cholesterol: 19 people, 27.94%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 16 people, 23.53%
Indigestion: 13 people, 19.12%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously